Figure KOL-1 Population Pyramid showing Age Distribution: 2012 KOLKATA

Similar documents
RURAL CANCER REGISTRY, AHMEDABAD DISTRICT The Gujarat Cancer & Research Institute, Ahmedabad

POPULATION BASED CANCER REGISTRY, BHOPAL Gandhi Medical College, Bhopal

Individual Registries Write-up with Table of Source of Registration. Bangalore - BLR Barshi - BRS Bhopal - BHP

POPULATION BASED RURAL CANCER REGISTRY, BARSHI (BARSHI, PARANDA & BHUM) Nargis Dutt Memorial Cancer Hospital, Barshi

Individual Registry Write-up: POPULATION BASED CANCER REGISTRY, MUMBAI Indian Cancer Society, Mumbai

POPULATION BASED CANCER REGISTRY, DELHI Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi.

Individual Registry Write-up: POPULATION BASED CANCER REGISTRY, Silchar town Silchar Medical College, Silchar. Dr. Sekhar Chakravarty

HospItal Based Cancer Registry

CANCER INCIDENCE IN BULGARIA 2006 ЗАБОЛЯЕМОСТ ОТ РАК В БЪЛГАРИЯ, 2006

Note that this publication utilizes population estimates that are based upon the United States 2010 and Canada 2011 censuses.

North America:

Cancer in North America: Volume Four: Cancer Survival in the United States and Canada

North America:

Table C-34 Resident Live Births, All Deaths, Infant, and Neonatal Deaths for Selected Municipalities, Number and Rate*: Pennsylvania, 2002

Statistical Appendix. List of tables

COUNTY PROFILE: Hockley County, Texas

Magnetic Resonance Imaging (MRI)

Table C-34 Resident Live Births, All Deaths, Infant, Neonatal, and Fetal Deaths for Selected Municipalities, Number and Rate*: Pennsylvania, 1998

Invasive Melanoma Mortality to Incidence Ratios by Local Health District in New South Wales

VCUG Preparation Book (Voiding Cystourethrogram) BC Children s Hospital

WHR Overview Comparison of Health Outcomes

Jess s bone marrow donation

Ben s stem cell transplant

Community Healthn eeds assessment

INFORMATION FOR SPONSORS AND EXHIBITORS. 37th European Congress of Cytology

Hospital Performance Report

Urology. WJ 100 U Urologic pathology with clinical and radiologic correlations / 1989

Community Health Status Assessment Findings

How long does levofloxacin take to work for pneumonia

World War II Veteran Honor Flight Austin Application and Pre Flight Checklist

Package leaflet: Information for the patient Levofloxacin 250 mg film-coated tablets Levofloxacin 500 mg film-coated tablets

BHF CVD STATISTICS COMPENDIUM

Vietnam War Veteran Honor Flight Austin Application and Pre Flight Checklist

Laparoscopy and Thoracoscopy in Small Animals VET /2018-E

2014 Aerospace Medical Certification Statistical Handbook

MEDICATION GUIDE Levofloxacin Tablets Rx Only

2019 Annual Conference on Genetics. Vienna Austria. June 29, Sponsored by the Archives of Applied Medicine

The Path to Good Health: A Toolkit for Parents

Krka s business performance in 2015

The Hon Jack Snelling MP Minister for Health; Professor Steve Wesselingh, Executive Director, SAHMRI;

Down Sydrome and You. A booklet for people with Down syndrome. Canada s national voice for individuals with Down syndrome

ELKS GRASSICK TRANSITION CAMP APPLICATION

STRONG START OHIO. Healthcare Quality Improvement for Mothers and Babies. Strong Start. for You and Your Baby

FEE. (circle one) T-Shirt Size: XXL. Height: Weight: Phone Number: Relationship: $375 $400 $25. Non-CPI Participant. Transportation $25) $75 $10

Published by the Stationery Office, Dublin, Ireland. Government Publications Sales Office, Sun Alliance House, Molesworth Street, Dublin 2,

MRI or Magnetic Resonance Imaging

Annual Flight Report. Adventist Heritage. June 17, 2011

Trout Processing. Evisceration, or gutting the fish, can be accomplished through a variety of techniques.

Medicinal springs - a gift of nature. The royal JEWEL of Bavaria.

Cultures, Specimen Collection for

Application for Employment Cabin Crew

PLEASE FILL OUT ALL FORMS BEFORE SENDING IN: THE CAMPER PHYSICAL RECORD MUST BE FILLED OUT AND SIGNED BY A PHYSICIAN.

Kids and Constipation:

Gigatome Phantom One. The biggest fully motorized heavy-duty sledge microtome for histology and material sciences

MEDICATION GUIDE. Levofloxacin (LEE-voe-FLOX-a-sin) Tablets USP Rx Only

More transplants new lives

CONCEPTUAL URBAN - ARCHITECTURAL STUDY IODINE WATER SPA SISCIA - POGORELAC, SISAK

CIRCUIT COURT. Court Case No.: THE ABOVE NAMED COMPLAINING WITNESS BEING DULY SWORN, ON INFORMATION AND BELIEF STATES THAT:

WH Hematology. Page 1

Cruising Through Neuro/ENT Imaging and the Panama Canal

MARIÁNSKÉ LÁZNĚ Czech Republic. Spa Treatments

Statistical Handbook Aerospace Medical Certification

3/28/2017. Disclosure of Relevant Financial Relationships FUNGUS IN FORMALIN. CASE 1 ADIASPIROMYCOSIS ADIASPIROMYCOSIS

IFCPC SAVE THE DATE INDIA 2020 OCTOBER 1-4, World Congress for Cervical Pathology and Colposcopy

Tonsils and Adenoids

2.1 All cabin crew shall undergo initial and renewal medical examination of equivalent to Class 2 Medical Examination.

What s inside. Page 03. Page 04. Page 16 Page 22 Page 27 Page 29 Page 34 Page 39 Page 43 Page 45 Page 47 Page 49. See the diagrams on page 51!

Inside you will find: How to prepare for your colonoscopy Information about your colonoscopy Answers to commonly asked questions

Krka s business performance in 2013

Europass website activity report 2017 (Iceland, Icelandic)

CT Scan UHN. Information for patients and families

YOU THE EARLY WEEKS: PARTNERS

LONGIDORUS PIUS SP. N. (NEMATODA: LONGIDORIDAE) FROM MACEDONIA

APPENDIX KING VISION VIDEO LARYNGOSCOPE

About Your PET-CT with FDG Tracer

CURRICULUM VITA KOTB MOHAMED BAKR.MD. Lecturer of General surgery. Assiut University Hospital. Assiut Egypt. Member of German society of surgery(dgsh)

MEDICATION GUIDE Levofloxacin Tablets 250 mg, 500 mg and 750 mg

GCSE Legacy and Revised Wales Results, June 2017.

Patient Visits: Services Provided Free of Charge 2012

NEPHROLOGY MEDICAL FORM

SPA TREATMENT & WELLNESS 2014 in the Czech Republic

NOTICE.

CIVIL AVIATION REQUIREMENTS SECTION 7 - FLIGHT CREW STANDARDS, TRAINING AND LICENSING SERIES C PART II EFFECTIVE: FORTHWITH

AVIATION MEDICINE 9/25/2014 WHAT DO YOUR PILOTS LOOK LIKE? WHAT DO YOUR PILOTS LOOK LIKE? WHAT DO YOUR PILOTS LOOK LIKE?

(ANZOD Registry) [Data collected to 31 st December 2004] Edited by. Mrs Leonie Excell Ms Penny Wride Professor Graeme R Russ

Organ Transplantation in Brazil

Geography Social Political Religion Intellectual Technology Economics

Application for Employment Cabin Crew

STUDENTS WILL BE ABLE TO IDENTIFY THE MAJOR GEOGRAPHIC FEATURES OF EGYPT AND THE SURROUNDING REGION

Tarpology 501. Advanced Shade Tarp Techniques for Paleontological Field Excavations; Strategies for field paleontology on a warming planet

Europass website activity report 2018 (Macedonia, the former Yugoslav Republic of, Macedonian)

Europass website activity report 2018 (Macedonia, the former Yugoslav Republic of, Macedonian)

Arranging haemodialysis for when you go on holiday. Information for patients Sheffield Kidney Institute (Renal Unit)

COLORADO 23.7 MILES ONE DAY GRANT WISHES AUGUST 10-12, 2018 COLORADO TRAIL SPONSORSHIP OPPORTUNITIES TRAILBLAZECHALLENGECO.ORG

American Indian/Alaskan Native Black or African American Hispanic/Latino Asian or Pacific Islander Caucasian/White Mix Other

Health Statistics 2016

Macon County, NC State of the County Health Report. Prepared by the Macon County Public Health Center & Healthy Carolinians of Macon County

RIO BRAVO. Club House Update Golf Maintenance Update Golfers Corner Membership News Events Gallery F&B Update August-September Calendar

Whizard. Series II. Taking trimmer technology to the next level. Models: 350M2 360M2 500M2 505M2 620M2 625M2

WELCOME TO SUMMER CAMP! SOME QUICK REMINDERS. Dear Parents/Guardians,

Transcription:

Figure KOL-1 Population Pyramid showing Age Distribution: 2012 64412 75+ 65059 52533 70-74 47749 66828 65-69 60746 100543 60-64 87815 120655 55-59 101658 151307 50-54 126478 172417 45-49 152920 187769 40-44 163793 196524 35-39 189462 194769 30-34 185224 204521 25-29 199595 202882 20-24 193942 190321 15-19 174646 172268 10-14 157063 141763 05-09 132201 118783 00-04 110686 15 12 9 Males 6 3 0 0 3 6 9 12 15 Females

TABLE KOL-2 Population by Five Year Age Group and Gender: 2012 Age Group Number and Relative Proportion(%) Males Females Number % Number % 00-04 118783 5.08 110686 5.15 05-09 141763 6.06 132201 6.15 10-14 172268 7.37 157063 7.31 15-19 190321 8.14 174646 8.13 20-24 202882 8.68 193942 9.02 25-29 204521 8.75 199595 9.29 30-34 194769 8.33 185224 8.62 35-39 196524 8.40 189462 8.82 40-44 187769 8.03 163793 7.62 45-49 172417 7.37 152920 7.12 50-54 151307 6.47 126478 5.89 55-59 120655 5.16 101658 4.73 60-64 100543 4.30 87815 4.09 65-69 66828 2.86 60746 2.83 70-74 52533 2.25 47749 2.22 75+ 64412 2.75 65059 3.03 Total 2338295 100.00 2149037 100.00

TABLE KOL-3(a): Number of Incident Cancers by Five Year Age Group and Site (ICD-10): 2012 Males %= Relative Proportion of Cancers of All Sites ICD-10 Site 00-04 05-09 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Unkn Total % C00 Lip - - - - - 1 1 1 1 - - 2 1 2-1 - 10 0.36 C01-C02 Tongue - - - - - 7 12 7 16 14 20 13 24 14 12 13-152 5.47 C03-C06 Mouth 1 - - - - 2 9 8 21 26 36 24 23 18 11 12-191 6.88 C07-C08 Salivary Gland - - - - - 1 - - 1 2 3 2 4 2 3 1-19 0.68 C09 Tonsil - - - - - - - - - 1 2 2 4 3 2 3-17 0.61 C10 Oth. Oropharynx - - - - - - - - 2-1 1 2 1 1 1-9 0.32 C11 Nasopharynx - - - 1 1-2 1 - - 1-1 2-1 - 10 0.36 C12-C13 Hypopharynx - - 1 - - - 2 - - 4 6 11 4 12 7 6-53 1.91 C14 Pharynx Unspecified - - - - - 1 - - 1 1 2 1 1 2 2 3-14 0.50 C15 Oesophagus - - - - - - - 1 2 6 9 10 10 13 10 14-75 2.70 C16 Stomach - - - - - 1 3 1 5 10 9 10 17 15 18 9-98 3.53 C17 Small Intestine - - - - - - - - - - 2-1 - 2 1-6 0.22 C18 Colon - - - - 2-5 6 5 8 11 15 17 9 11 24-113 4.07 C19-C20 Rectum - - 1-1 1 2 7 6 8 7 8 8 3 8 7-67 2.41 C21 Anus & Anal Canal - - - - 1-2 2 1 - - 3 2-1 1-13 0.47 C22 Liver - - - - - 1 4 4 1 6 10 11 15 10 9 13-84 3.02 C23-C24 Gallbladder etc. - 1 - - - - 1 1 4 7 5 15 15 11 9 22-91 3.28 C25 Pancreas - - - - - - 4 1-5 4 11 6 11 7 12-61 2.20 C30-C31 Nose, Sinuses etc. - - - - - - - - - - 1 4-1 2-1 9 0.32 C32 Larynx - - - 1-1 1 2 2 11 16 18 22 34 20 21-149 5.37 C33-C34 Lung etc. - - - - 2 1 2 2 11 24 52 66 96 89 80 95 4 524 18.87 C37-C38 Other Thoracic Organs - - - - - - - 1 3-1 1-2 1 - - 9 0.32 C40-C41 Bone 1-1 4 1 2 2 1 2 5 1 3 2 1 2 4 1 33 1.19 C43 Melanoma of Skin - - - - - 1 - - 3 1 4-5 4 2 2-22 0.79 C44 Other Skin - - - - - - 1 2-2 2 3 1 2 1 4-18 0.65 C45 Mesothelioma - - - - - - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue - - 1 2 1 1 4 3-1 2 3 5 1 4-2 30 1.08 C50 Breast - - - - - - - 1 1 3 3 4 2 1 4 5-24 0.86 C60 Penis - - - - 2-1 - 1 2 7 4 1 3 1 3-25 0.90 C61 Prostate - - - - - - - - - 2 11 16 23 41 42 93 1 229 8.25 C62 Testis - - 1 - - 3 3 4 5 1 3 - - - - - - 20 0.72 C63 Other Male Genital - - - - - - - - - - - - - - - - - - - C64 Kidney etc. - - - - - - 2 1 2 4 5 10 11 6 4 12-57 2.05 C65 Renal Pelvis - - - - - - - - - - - - - - - - - - - C66 Ureter - - - - - - - - - - - - - - - - - - - C67 Urinary Bladder - - - 1 - - 1-4 3 12 15 17 18 17 20-108 3.89 C68 Uns.Urinary Organs 1 - - - - - - - - - 1 - - - - - - 2 0.07 C69 Eye 1 1 - - - - - 2 - - - - - - - 1-5 0.18 C70-C72 Brain, Nervous System 1 - - 1-1 - 3 3 4 7 6 5 7 2 5-45 1.62 C73 Thyroid - - - 1 1 2 2 2 3 2 3 4 1 3 5 - - 29 1.04 C74 Adrenal Gland - - - - - - - - - - - - - - - - - - - C81 Hodgkins Disease - - 2 1 2 3 1-4 2 5 5 3 1-1 - 30 1.08 C82-C85 NHL - 2 1 2 2 4 5 5 3 3 10 10 10 11 6 7 2 83 2.99 C88 Malig Imn.Prol D - - - - - - - - - - - - - - - - - - - C90 Multiple Myeloma - - - - - - - - 1 5 3 7 4 9 5 12-46 1.66 C91 Lymphoid Leuk. 2 3 1 - - - 1 1 1 1-3 3 2 4 1-23 0.83 C92-C94 Myeloid Leukaemia 1 2 2 4 2 2 3 4 7 2 2 10 3 4 2 5-55 1.98 C95 Leukaemia Uns - - - - - - - - - - 3 - - 1 - - - 4 0.14 C96 CMD,O&U LMH - - - - - - - - - - - - - - - - - - - O&U* Other and Uns - 1 1 - - 2 4 3 3 4 14 9 20 14 18 21 1 115 4.14 All Sites 8 10 12 18 18 38 80 77 125 180 296 340 389 383 335 456 12 2777 100.0

TABLE KOL-3(b): Number of Incident Cancers by Five Year Age Group and Site (ICD-10): 2012 Females %= Relative Proportion of Cancers of All Sites ICD-10 Site 00-04 05-09 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Unkn Total % C00 Lip - - - - - - - - - 2 - - - 3 1 - - 6 0.23 C01-C02 Tongue - - - - - 2-6 3 6 5 9 14 5 6 2 2 60 2.31 C03-C06 Mouth - - - 1 - - 1 3 5 9 13 9 10 8 2 16-77 2.97 C07-C08 Salivary Gland - - - - - 1 1-1 - 1 1 1-1 1-8 0.31 C09 Tonsil - - - - - - - - 3 1 1-1 2 1 - - 9 0.35 C10 Oth. Oropharynx - - - - - - - - 1 - - - - - 3 - - 4 0.15 C11 Nasopharynx - - - - - - - - - - 1 1 - - - 1-3 0.12 C12-C13 Hypopharynx - - - - - - - - - - 2 2 2 2 1 1-10 0.39 C14 Pharynx Unspecified - - - - - - - - - - - - - - 1 3-4 0.15 C15 Oesophagus - - - - - - - 1 3 3 2 7 7 3 8 11-45 1.73 C16 Stomach - - - 1-1 3 3 3 2 8 10 6 6 10 11-64 2.47 C17 Small Intestine - - - 1 - - - - 1-1 - - - - - - 3 0.12 C18 Colon - - - - - - 3-2 8 6 8 7 5 8 5 1 53 2.04 C19-C20 Rectum 1 - - - 1 1 3 3 3 4 4 5 7 2 3 10 2 49 1.89 C21 Anus & Anal Canal - - - - - - - - - - - 1 3 2 1 1-8 0.31 C22 Liver 1 - - - - 1 - - 2 2 5 9 11 1 4 5-41 1.58 C23-C24 Gallbladder etc. 1 1 - - - 1 4 5 16 18 24 20 28 21 22 30 1 192 7.40 C25 Pancreas - - - - 1 - - 1 1-4 6 4 6 2 5-30 1.16 C30-C31 Nose, Sinuses etc. - - - - - - - - - - - 1 1 1-1 - 4 0.15 C32 Larynx - - - - - 1-2 2 2 1 4 3 4 2 5-26 1.00 C33-C34 Lung etc. - - - 1-2 2 8 11 16 21 17 24 31 21 30 1 185 7.13 C37-C38 Other Thoracic Organs - - - - - - - - 2 1 2-2 - 1 2-10 0.39 C40-C41 Bone - - 3 1 4-1 - 1 3 4 1 1 1 2 3-25 0.96 C43 Melanoma of Skin - - - - - - 2 - - 7 2-2 2 3 - - 18 0.69 C44 Other Skin - - - - - - 1 1 1 2 1-2 1 2 2-13 0.50 C45 Mesothelioma - - - - - - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue 1 - - - - 2 2 2-3 2 2-1 3 - - 18 0.69 C50 Breast - - - - 4 10 28 49 68 93 89 101 64 57 36 53 8 660 25.42 C51 Vulva - - - 1 - - - - - 1 2-2 2 3 - - 11 0.42 C52 Vagina - - - - - - - - - 1 3 2 2 1 1 4-14 0.54 C53 Cervix Uteri - - - - - 1 5 16 28 43 46 26 29 31 19 17 1 262 10.09 C54 Corpus Uteri - - - - - - 1 3 7 9 11 18 21 11 9 6 1 97 3.74 C55 Uterus Unspecified - - - 1 - - - 1 4 3 5 3 2 3 1 7 1 31 1.19 C56 Ovary etc. - - 1-1 6 12 12 28 25 28 22 23 19 11 14 1 203 7.82 C57 Other Female Genital - - - - - - - - - - - - - - - 1-1 0.04 C58 Placenta - - - - - - - - - - - - - - - - - - - C64 Kidney etc. - - - 1 - - 1 4 3 1 4 4 4-1 6 1 30 1.16 C65 Renal Pelvis - - - - - - - - - - - - - - - - - - - C66 Ureter - - - - - - - - - - - - - 1 - - - 1 0.04 C67 Urinary Bladder 1 - - - 1 - - - 1 1 2 1-4 4 2-17 0.65 C68 Uns.Urinary Organs - - - - - - - - - 1 1-1 - - - - 3 0.12 C69 Eye 1 - - - - - - - - 1-1 - - - 1-4 0.15 C70-C72 Brain, Nervous System 1-1 3 1 2-2 4 4 3-3 3 3 1-31 1.19 C73 Thyroid - - - 1 2 10 3 6 7 6 2 2 7 4 3 - - 53 2.04 C74 Adrenal Gland - - - - - - - - - - - - - - - - - - - C81 Hodgkins Disease - - - 2 2-1 2 1 1 1 1-1 - 1-13 0.50 C82-C85 NHL - 1 2-2 - - 1 3 3 6 8 5 11 1 8-51 1.96 C88 Malig Imn.Prol D - - - - - - - - - - - - - - - - - - - C90 Multiple Myeloma - 1 - - - - - 2 - - 3 3 3 4 3 2-21 0.81 C91 Lymphoid Leuk. 2 3 - - - - 1 1 1 2-1 1 1 2 2-17 0.65 C92-C94 Myeloid Leukaemia 1 3 2 1 1-1 1 1 1 1 5 1 1 3 4-27 1.04 C95 Leukaemia Uns - - - - - - - 1 1 1 1 - - 1-1 - 6 0.23 C96 CMD,O&U LMH - - - - - - - - - - - - - - - - - - - O&U* Other and Uns 1 - - - 2 1 - - 5 3 5 9 16 5 16 15-78 3.00 All Sites 11 9 9 15 22 42 76 136 223 289 323 320 320 267 224 290 20 2596 100.0

TABLE KOL-4(a): Average Annual Age Specific, Crude (CR), Age Adjusted (AAR) (with Standard Error (SE)) and Truncated (35-64 yrs) (TR) Incidence Rate per 100,000 population:2012 Males ICD-10 00-04 05-09 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ CR AAR SE TR C00 - - - - - 0.5 0.5 0.5 0.5 - - 1.7 1.0 3.0-1.6 0.4 0.36 0.11 0.5 C01-C02 - - - - - 3.4 6.2 3.6 8.5 8.1 13.2 10.8 23.9 20.9 22.8 20.2 6.5 5.39 0.44 10.5 C03-C06 0.8 - - - - 1.0 4.6 4.1 11.2 15.1 23.8 19.9 22.9 26.9 20.9 18.6 8.2 6.78 0.50 15.2 C07-C08 - - - - - 0.5 - - 0.5 1.2 2.0 1.7 4.0 3.0 5.7 1.6 0.8 0.70 0.16 1.4 C09 - - - - - - - - - 0.6 1.3 1.7 4.0 4.5 3.8 4.7 0.7 0.63 0.15 1.1 C10 - - - - - - - - 1.1-0.7 0.8 2.0 1.5 1.9 1.6 0.4 0.32 0.11 0.7 C11 - - - 0.5 0.5-1.0 0.5 - - 0.7-1.0 3.0-1.6 0.4 0.37 0.12 0.3 C12-C13 - - 0.6 - - - 1.0 - - 2.3 4.0 9.1 4.0 18.0 13.3 9.3 2.3 1.97 0.27 2.8 C14 - - - - - 0.5 - - 0.5 0.6 1.3 0.8 1.0 3.0 3.8 4.7 0.6 0.50 0.14 0.7 C15 - - - - - - - 0.5 1.1 3.5 5.9 8.3 9.9 19.5 19.0 21.7 3.2 2.73 0.32 4.3 C16 - - - - - 0.5 1.5 0.5 2.7 5.8 5.9 8.3 16.9 22.4 34.3 14.0 4.2 3.61 0.37 5.9 C17 - - - - - - - - - - 1.3-1.0-3.8 1.6 0.3 0.21 0.09 0.3 C18 - - - - 1.0-2.6 3.1 2.7 4.6 7.3 12.4 16.9 13.5 20.9 37.3 4.8 3.96 0.38 7.0 C19-C20 - - 0.6-0.5 0.5 1.0 3.6 3.2 4.6 4.6 6.6 8.0 4.5 15.2 10.9 2.9 2.35 0.29 4.8 C21 - - - - 0.5-1.0 1.0 0.5 - - 2.5 2.0-1.9 1.6 0.6 0.44 0.12 0.9 C22 - - - - - 0.5 2.1 2.0 0.5 3.5 6.6 9.1 14.9 15.0 17.1 20.2 3.6 3.01 0.33 5.3 C23-C24-0.7 - - - - 0.5 0.5 2.1 4.1 3.3 12.4 14.9 16.5 17.1 34.2 3.9 3.28 0.35 5.4 C25 - - - - - - 2.1 0.5-2.9 2.6 9.1 6.0 16.5 13.3 18.6 2.6 2.20 0.28 3.0 C30-C31 - - - - - - - - - - 0.7 3.3-1.5 3.8-0.4 0.29 0.10 0.5 C32 - - - 0.5-0.5 0.5 1.0 1.1 6.4 10.6 14.9 21.9 50.9 38.1 32.6 6.4 5.57 0.46 8.1 C33-C34 - - - - 1.0 0.5 1.0 1.0 5.9 13.9 34.4 54.7 95.5 133.2 152.3 147.5 22.4 19.14 0.85 28.9 C37-C38 - - - - - - - 0.5 1.6-0.7 0.8-3.0 1.9-0.4 0.32 0.11 0.6 C40-C41 0.8-0.6 2.1 0.5 1.0 1.0 0.5 1.1 2.9 0.7 2.5 2.0 1.5 3.8 6.2 1.4 1.25 0.23 1.6 C43 - - - - - 0.5 - - 1.6 0.6 2.6-5.0 6.0 3.8 3.1 0.9 0.82 0.18 1.5 C44 - - - - - - 0.5 1.0-1.2 1.3 2.5 1.0 3.0 1.9 6.2 0.8 0.62 0.15 1.1 C45 - - - - - - - - - - - - - - - - - - - - C46 - - - - - - - - - - - - - - - - - - - - C47+C49 - - 0.6 1.1 0.5 0.5 2.1 1.5-0.6 1.3 2.5 5.0 1.5 7.6-1.3 1.04 0.20 1.6 C50 - - - - - - - 0.5 0.5 1.7 2.0 3.3 2.0 1.5 7.6 7.8 1.0 0.83 0.17 1.5 C60 - - - - 1.0-0.5-0.5 1.2 4.6 3.3 1.0 4.5 1.9 4.7 1.1 0.88 0.18 1.6 C61 - - - - - - - - - 1.2 7.3 13.3 22.9 61.4 79.9 144.4 9.8 8.21 0.55 6.1 C62 - - 0.6 - - 1.5 1.5 2.0 2.7 0.6 2.0 - - - - - 0.9 0.68 0.15 1.3 C63 - - - - - - - - - - - - - - - - - - - - C64 - - - - - - 1.0 0.5 1.1 2.3 3.3 8.3 10.9 9.0 7.6 18.6 2.4 2.02 0.27 3.8 C65 - - - - - - - - - - - - - - - - - - - - C66 - - - - - - - - - - - - - - - - - - - - C67 - - - 0.5 - - 0.5-2.1 1.7 7.9 12.4 16.9 26.9 32.4 31.1 4.6 3.96 0.38 5.8 C68 0.8 - - - - - - - - - 0.7 - - - - - 0.1 0.13 0.11 0.1 C69 0.8 0.7 - - - - - 1.0 - - - - - - - 1.6 0.2 0.26 0.13 0.2 C70-C72 0.8 - - 0.5-0.5-1.5 1.6 2.3 4.6 5.0 5.0 10.5 3.8 7.8 1.9 1.69 0.26 3.1 C73 - - - 0.5 0.5 1.0 1.0 1.0 1.6 1.2 2.0 3.3 1.0 4.5 9.5-1.2 1.05 0.20 1.6 C74 - - - - - - - - - - - - - - - - - - - - C81 - - 1.2 0.5 1.0 1.5 0.5-2.1 1.2 3.3 4.1 3.0 1.5-1.6 1.3 1.10 0.20 2.1 C82-C85-1.4 0.6 1.1 1.0 2.0 2.6 2.5 1.6 1.7 6.6 8.3 9.9 16.5 11.4 10.9 3.5 3.03 0.34 4.6 C88 - - - - - - - - - - - - - - - - - - - - C90 - - - - - - - - 0.5 2.9 2.0 5.8 4.0 13.5 9.5 18.6 2.0 1.66 0.25 2.2 C91 1.7 2.1 0.6 - - - 0.5 0.5 0.5 0.6-2.5 3.0 3.0 7.6 1.6 1.0 1.09 0.25 1.0 C92-C94 0.8 1.4 1.2 2.1 1.0 1.0 1.5 2.0 3.7 1.2 1.3 8.3 3.0 6.0 3.8 7.8 2.4 2.13 0.30 3.0 C95 - - - - - - - - - - 2.0 - - 1.5 - - 0.2 0.14 0.07 0.3 C96 - - - - - - - - - - - - - - - - - - - - O&U* - 0.7 0.6 - - 1.0 2.1 1.5 1.6 2.3 9.3 7.5 19.9 20.9 34.3 32.6 4.9 4.17 0.40 6.1 All Sites 6.7 7.1 7.0 9.5 8.9 18.6 41.1 39.2 66.6 104.4 195.6 281.8 386.9 573.1 637.7 707.9 118.8 100.9 1.94 158.5

TABLE KOL-4(b): Average Annual Age Specific, Crude (CR), Age Adjusted (AAR) (with Standard Error (SE)) and Truncated (35-64 yrs) (TR) Incidence Rate per 100,000 population:2012 Females ICD-10 00-04 05-09 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ CR AAR SE TR C00 - - - - - - - - - 1.3 - - - 4.9 2.1-0.3 0.27 0.11 0.3 C01-C02 - - - - - 1.0-3.2 1.8 3.9 4.0 8.9 15.9 8.2 12.6 3.1 2.8 2.36 0.31 5.6 C03-C06 - - - 0.6 - - 0.5 1.6 3.1 5.9 10.3 8.9 11.4 13.2 4.2 24.6 3.6 3.01 0.35 6.3 C07-C08 - - - - - 0.5 0.5-0.6-0.8 1.0 1.1-2.1 1.5 0.4 0.31 0.11 0.5 C09 - - - - - - - - 1.8 0.7 0.8-1.1 3.3 2.1-0.4 0.37 0.13 0.8 C10 - - - - - - - - 0.6 - - - - - 6.3-0.2 0.16 0.08 0.1 C11 - - - - - - - - - - 0.8 1.0 - - - 1.5 0.1 0.11 0.06 0.3 C12-C13 - - - - - - - - - - 1.6 2.0 2.3 3.3 2.1 1.5 0.5 0.42 0.13 0.8 C14 - - - - - - - - - - - - - - 2.1 4.6 0.2 0.13 0.07 - C15 - - - - - - - 0.5 1.8 2.0 1.6 6.9 8.0 4.9 16.8 16.9 2.1 1.75 0.26 3.0 C16 - - - 0.6-0.5 1.6 1.6 1.8 1.3 6.3 9.8 6.8 9.9 20.9 16.9 3.0 2.51 0.32 4.1 C17 - - - 0.6 - - - - 0.6-0.8 - - - - - 0.1 0.13 0.07 0.2 C18 - - - - - - 1.6-1.2 5.2 4.7 7.9 8.0 8.2 16.8 7.7 2.5 2.09 0.29 4.1 C19-C20 0.9 - - - 0.5 0.5 1.6 1.6 1.8 2.6 3.2 4.9 8.0 3.3 6.3 15.4 2.3 1.85 0.28 3.3 C21 - - - - - - - - - - - 1.0 3.4 3.3 2.1 1.5 0.4 0.35 0.12 0.6 C22 0.9 - - - - 0.5 - - 1.2 1.3 4.0 8.9 12.5 1.6 8.4 7.7 1.9 1.72 0.28 3.9 C23-C24 0.9 0.8 - - - 0.5 2.2 2.6 9.8 11.8 19.0 19.7 31.9 34.6 46.1 46.1 8.9 7.70 0.57 14.4 C25 - - - - 0.5 - - 0.5 0.6-3.2 5.9 4.6 9.9 4.2 7.7 1.4 1.22 0.23 2.1 C30-C31 - - - - - - - - - - - 1.0 1.1 1.6-1.5 0.2 0.17 0.08 0.3 C32 - - - - - 0.5-1.1 1.2 1.3 0.8 3.9 3.4 6.6 4.2 7.7 1.2 1.02 0.20 1.8 C33-C34 - - - 0.6-1.0 1.1 4.2 6.7 10.5 16.6 16.7 27.3 51.0 44.0 46.1 8.6 7.41 0.55 12.5 C37-C38 - - - - - - - - 1.2 0.7 1.6-2.3-2.1 3.1 0.5 0.39 0.12 0.9 C40-C41 - - 1.9 0.6 2.1-0.5-0.6 2.0 3.2 1.0 1.1 1.6 4.2 4.6 1.2 1.04 0.21 1.3 C43 - - - - - - 1.1 - - 4.6 1.6-2.3 3.3 6.3-0.8 0.73 0.17 1.4 C44 - - - - - - 0.5 0.5 0.6 1.3 0.8-2.3 1.6 4.2 3.1 0.6 0.50 0.14 0.9 C45 - - - - - - - - - - - - - - - - - - - - C46 - - - - - - - - - - - - - - - - - - - - C47+C49 0.9 - - - - 1.0 1.1 1.1-2.0 1.6 2.0-1.6 6.3-0.8 0.77 0.19 1.1 C50 - - - - 2.1 5.0 15.1 25.9 41.5 60.8 70.4 99.4 72.9 93.8 75.4 81.5 30.7 25.52 1.01 58.4 C51 - - - 0.6 - - - - - 0.7 1.6-2.3 3.3 6.3-0.5 0.49 0.15 0.7 C52 - - - - - - - - - 0.7 2.4 2.0 2.3 1.6 2.1 6.1 0.7 0.54 0.15 1.1 C53 - - - - - 0.5 2.7 8.4 17.1 28.1 36.4 25.6 33.0 51.0 39.8 26.1 12.2 10.43 0.65 23.8 C54 - - - - - - 0.5 1.6 4.3 5.9 8.7 17.7 23.9 18.1 18.8 9.2 4.5 3.94 0.41 9.0 C55 - - - 0.6 - - - 0.5 2.4 2.0 4.0 3.0 2.3 4.9 2.1 10.8 1.4 1.16 0.21 2.3 C56 - - 0.6-0.5 3.0 6.5 6.3 17.1 16.3 22.1 21.6 26.2 31.3 23.0 21.5 9.4 7.96 0.57 17.4 C57 - - - - - - - - - - - - - - - 1.5 0.0 0.03 0.03 - C58 - - - - - - - - - - - - - - - - - - - - C64 - - - 0.6 - - 0.5 2.1 1.8 0.7 3.2 3.9 4.6-2.1 9.2 1.4 1.08 0.20 2.5 C65 - - - - - - - - - - - - - - - - - - - - C66 - - - - - - - - - - - - - 1.6 - - 0.0 0.05 0.05 - C67 0.9 - - - 0.5 - - - 0.6 0.7 1.6 1.0-6.6 8.4 3.1 0.8 0.77 0.20 0.6 C68 - - - - - - - - - 0.7 0.8-1.1 - - - 0.1 0.12 0.07 0.4 C69 0.9 - - - - - - - - 0.7-1.0 - - - 1.5 0.2 0.22 0.13 0.3 C70-C72 0.9-0.6 1.7 0.5 1.0-1.1 2.4 2.6 2.4-3.4 4.9 6.3 1.5 1.4 1.37 0.26 2.0 C73 - - - 0.6 1.0 5.0 1.6 3.2 4.3 3.9 1.6 2.0 8.0 6.6 6.3-2.5 2.11 0.29 3.7 C74 - - - - - - - - - - - - - - - - - - - - C81 - - - 1.1 1.0-0.5 1.1 0.6 0.7 0.8 1.0-1.6-1.5 0.6 0.52 0.15 0.7 C82-C85-0.8 1.3-1.0 - - 0.5 1.8 2.0 4.7 7.9 5.7 18.1 2.1 12.3 2.4 2.14 0.31 3.4 C88 - - - - - - - - - - - - - - - - - - - - C90-0.8 - - - - - 1.1 - - 2.4 3.0 3.4 6.6 6.3 3.1 1.0 0.90 0.20 1.4 C91 1.8 2.3 - - - - 0.5 0.5 0.6 1.3-1.0 1.1 1.6 4.2 3.1 0.8 0.90 0.24 0.7 C92-C94 0.9 2.3 1.3 0.6 0.5-0.5 0.5 0.6 0.7 0.8 4.9 1.1 1.6 6.3 6.1 1.3 1.26 0.26 1.3 C95 - - - - - - - 0.5 0.6 0.7 0.8 - - 1.6-1.5 0.3 0.23 0.09 0.5 C96 - - - - - - - - - - - - - - - - - - - - O&U* 0.9 - - - 1.0 0.5 - - 3.1 2.0 4.0 8.9 18.2 8.2 33.5 23.1 3.6 3.19 0.37 5.1 All Sites 9.9 6.8 5.7 8.6 11.3 21.0 41.0 71.8 136.1 189.0 255.4 314.8 364.4 439.5 469.1 445.7 120.8 103.4 2.07 205.6

ICD-10 Site TABLE KOL-5(a): Number (#) and Proportion (%) of Cancers by Site (ICD-10) and Method of Diagnosis: 2012 Males Microscopic X-ray/Imaging Clinical Others D.C.O Unknown Total # % # % # % # % # % # % # % C00 Lip 10 100.0 - - - - - - - - - - 10 100.0 C01-C02 Tongue 130 85.5 - - 3 2.0 - - 17 11.2 2 1.3 152 100.0 C03-C06 Mouth 164 85.9 - - 7 3.7 - - 19 9.9 1 0.5 191 100.0 C07-C08 Salivary Gland 14 73.7 - - 1 5.3 - - 4 21.1 - - 19 100.0 C09 Tonsil 16 94.1 - - - - - - 1 5.9 - - 17 100.0 C10 Oth. Oropharynx 7 77.8 - - - - - - 2 22.2 - - 9 100.0 C11 Nasopharynx 6 60.0 - - - - - - 4 40.0 - - 10 100.0 C12-C13 Hypopharynx 51 96.2 - - - - - - 2 3.8 - - 53 100.0 C14 Pharynx Unspecified 3 21.4 - - - - - - 11 78.6 - - 14 100.0 C15 Oesophagus 49 65.3 - - - - 1 1.3 25 33.3 - - 75 100.0 C16 Stomach 65 66.3 1 1.0 - - 1 1.0 31 31.6 - - 98 100.0 C17 Small Intestine 5 83.3 - - - - - - 1 16.7 - - 6 100.0 C18 Colon 84 74.3 2 1.8 - - - - 27 23.9 - - 113 100.0 C19-C20 Rectum 53 79.1 - - - - - - 14 20.9 - - 67 100.0 C21 Anus & Anal Canal 10 76.9 - - - - - - 3 23.1 - - 13 100.0 C22 Liver 35 41.7 - - - - - - 47 56.0 2 2.4 84 100.0 C23-C24 Gallbladder etc. 45 49.5 3 3.3 - - 1 1.1 42 46.2 - - 91 100.0 C25 Pancreas 26 42.6 4 6.6 - - 1 1.6 30 49.2 - - 61 100.0 C30-C31 Nose, Sinuses etc. 8 88.9 - - - - - - 1 11.1 - - 9 100.0 C32 Larynx 117 78.5 - - - - - - 32 21.5 - - 149 100.0 C33-C34 Lung etc. 361 68.9 3 0.6 1 0.2 - - 157 30.0 2 0.4 524 100.0 C37-C38 Other Thoracic Organs 8 88.9 - - - - - - 1 11.1 - - 9 100.0 C40-C41 Bone 25 75.8 - - - - - - 8 24.2 - - 33 100.0 C43 Melanoma of Skin 22 100.0 - - - - - - - - - - 22 100.0 C44 Other Skin 15 83.3 - - - - - - 3 16.7 - - 18 100.0 C45 Mesothelioma - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue 29 96.7 - - - - - - 1 3.3 - - 30 100.0 C50 Breast 21 87.5 - - - - - - 3 12.5 - - 24 100.0 C60 Penis 20 80.0 - - - - - - 5 20.0 - - 25 100.0 C61 Prostate 173 75.5 1 0.4 1 0.4 2 0.9 51 22.3 1 0.4 229 100.0 C62 Testis 19 95.0 - - - - - - - - 1 5.0 20 100.0 C63 Other Male Genital - - - - - - - - - - - - - - C64 Kidney etc. 42 73.7 - - - - - - 15 26.3 - - 57 100.0 C65 Renal Pelvis - - - - - - - - - - - - - - C66 Ureter - - - - - - - - - - - - - - C67 Urinary Bladder 87 80.6 - - - - - - 19 17.6 2 1.9 108 100.0 C68 Uns.Urinary Organs 1 50.0 - - - - - - 1 50.0 - - 2 100.0 C69 Eye 5 100.0 - - - - - - - - - - 5 100.0 C70-C72 Brain, Nervous System 29 64.4 - - - - - - 14 31.1 2 4.4 45 100.0 C73 Thyroid 27 93.1 - - - - - - 2 6.9 - - 29 100.0 C74 Adrenal Gland - - - - - - - - - - - - - - C81 Hodgkins Disease 24 80.0 - - - - - - 5 16.7 1 3.3 30 100.0 C82-C85 NHL 63 75.9 - - - - 1 1.2 18 21.7 1 1.2 83 100.0 C88 Malig Imn.Prol D - - - - - - - - - - - - - - C90 Multiple Myeloma 34 73.9 - - - - 1 2.2 11 23.9 - - 46 100.0 C91 Lymphoid Leuk. 19 82.6 - - - - - - 3 13.0 1 4.3 23 100.0 C92-C94 Myeloid Leukaemia 37 67.3 - - - - - - 18 32.7 - - 55 100.0 C95 Leukaemia Uns 1 25.0 - - - - - - 3 75.0 - - 4 100.0 C96 CMD,O&U LMH - - - - - - - - - - - - - - O&U* Other and Uns 48 41.7 3 2.6 1 0.9 - - 62 53.9 1 0.9 115 100.0 All Sites 2008 72.3 17 0.6 14 0.5 8 0.3 713 25.7 17 0.6 2777 100.0

ICD-10 Site TABLE KOL-5(b): Number (#) and Proportion (%) of Cancers by Site (ICD-10) and Method of Diagnosis: 2012 Females Microscopic X-ray/Imaging Clinical Others D.C.O Unknown Total # % # % # % # % # % # % # % C00 Lip 4 66.7 - - - - - - 1 16.7 1 16.7 6 100.0 C01-C02 Tongue 49 81.7 - - 2 3.3 - - 9 15.0 - - 60 100.0 C03-C06 Mouth 63 81.8 - - 1 1.3 - - 13 16.9 - - 77 100.0 C07-C08 Salivary Gland 8 100.0 - - - - - - - - - - 8 100.0 C09 Tonsil 8 88.9 - - - - - - - - 1 11.1 9 100.0 C10 Oth. Oropharynx 4 100.0 - - - - - - - - - - 4 100.0 C11 Nasopharynx 2 66.7 - - - - - - 1 33.3 - - 3 100.0 C12-C13 Hypopharynx 8 80.0 - - - - - - 2 20.0 - - 10 100.0 C14 Pharynx Unspecified 1 25.0 - - - - - - 3 75.0 - - 4 100.0 C15 Oesophagus 25 55.6 - - - - 3 6.7 17 37.8 - - 45 100.0 C16 Stomach 43 67.2 - - - - 1 1.6 20 31.3 - - 64 100.0 C17 Small Intestine 3 100.0 - - - - - - - - - - 3 100.0 C18 Colon 36 67.9 - - - - - - 17 32.1 - - 53 100.0 C19-C20 Rectum 32 65.3 2 4.1 - - - - 15 30.6 - - 49 100.0 C21 Anus & Anal Canal 8 100.0 - - - - - - - - - - 8 100.0 C22 Liver 20 48.8 - - - - - - 20 48.8 1 2.4 41 100.0 C23-C24 Gallbladder etc. 99 51.6 5 2.6 - - 2 1.0 85 44.3 1 0.5 192 100.0 C25 Pancreas 15 50.0 - - - - - - 15 50.0 - - 30 100.0 C30-C31 Nose, Sinuses etc. 4 100.0 - - - - - - - - - - 4 100.0 C32 Larynx 19 73.1 - - - - - - 6 23.1 1 3.8 26 100.0 C33-C34 Lung etc. 120 64.9 1 0.5 - - - - 64 34.6 - - 185 100.0 C37-C38 Other Thoracic Organs 9 90.0 - - - - - - 1 10.0 - - 10 100.0 C40-C41 Bone 23 92.0 - - - - - - 2 8.0 - - 25 100.0 C43 Melanoma of Skin 16 88.9 - - 2 11.1 - - - - - - 18 100.0 C44 Other Skin 11 84.6 - - - - - - 2 15.4 - - 13 100.0 C45 Mesothelioma - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue 17 94.4 - - - - - - 1 5.6 - - 18 100.0 C50 Breast 570 86.4 2 0.3 2 0.3 2 0.3 80 12.1 4 0.6 660 100.0 C51 Vulva 10 90.9 - - - - - - 1 9.1 - - 11 100.0 C52 Vagina 14 100.0 - - - - - - - - - - 14 100.0 C53 Cervix Uteri 216 82.4 2 0.8 7 2.7 - - 37 14.1 - - 262 100.0 C54 Corpus Uteri 85 87.6 1 1.0 - - - - 10 10.3 1 1.0 97 100.0 C55 Uterus Unspecified 12 38.7 - - - - - - 19 61.3 - - 31 100.0 C56 Ovary etc. 155 76.4 3 1.5 - - - - 45 22.2 - - 203 100.0 C57 Other Female Genital 1 100.0 - - - - - - - - - - 1 100.0 C58 Placenta - - - - - - - - - - - - - - C64 Kidney etc. 22 73.3 - - - - - - 8 26.7 - - 30 100.0 C65 Renal Pelvis - - - - - - - - - - - - - - C66 Ureter - - - - - - - - 1 100.0 - - 1 100.0 C67 Urinary Bladder 15 88.2 - - - - - - 2 11.8 - - 17 100.0 C68 Uns.Urinary Organs 3 100.0 - - - - - - - - - - 3 100.0 C69 Eye 3 75.0 - - - - - - 1 25.0 - - 4 100.0 C70-C72 Brain, Nervous System 22 71.0 - - - - - - 9 29.0 - - 31 100.0 C73 Thyroid 46 86.8 - - - - - - 7 13.2 - - 53 100.0 C74 Adrenal Gland - - - - - - - - - - - - - - C81 Hodgkins Disease 10 76.9 - - - - - - 3 23.1 - - 13 100.0 C82-C85 NHL 47 92.2 - - - - - - 4 7.8 - - 51 100.0 C88 Malig Imn.Prol D - - - - - - - - - - - - - - C90 Multiple Myeloma 14 66.7 1 4.8 - - - - 6 28.6 - - 21 100.0 C91 Lymphoid Leuk. 14 82.4 - - - - - - 3 17.6 - - 17 100.0 C92-C94 Myeloid Leukaemia 20 74.1 - - - - - - 7 25.9 - - 27 100.0 C95 Leukaemia Uns 3 50.0 - - - - - - 3 50.0 - - 6 100.0 C96 CMD,O&U LMH - - - - - - - - - - - - - - O&U* Other and Uns 32 41.0 - - - - - - 46 59.0 - - 78 100.0 All Sites 1961 75.5 17 0.7 14 0.5 8 0.3 586 22.6 10 0.4 2596 100.0

TABLE KOL-6(a): Number (#) and Proportion (%) of Cancers by Site (ICD-10) and Detailed Microscopic Diagnosis: 2012 Males ICD-10 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total # % # % # % # % # % # % # % C00 Lip 9 90.0 - - 1 10.0 - - - - - - 10 100.0 C01-C02 Tongue 120 78.9 1 0.7 9 5.9 - - - - 22 14.5 152 100.0 C03-C06 Mouth 152 79.6 - - 12 6.3 - - - - 27 14.1 191 100.0 C07-C08 Salivary Gland 9 47.4 - - 5 26.3 - - - - 5 26.3 19 100.0 C09 Tonsil 15 88.2 - - 1 5.9 - - - - 1 5.9 17 100.0 C10 Oth. Oropharynx 4 44.4 - - 3 33.3 - - - - 2 22.2 9 100.0 C11 Nasopharynx 6 60.0 - - - - - - - - 4 40.0 10 100.0 C12-C13 Hypopharynx 41 77.4 1 1.9 9 17.0 - - - - 2 3.8 53 100.0 C14 Pharynx Unspecified 3 21.4 - - - - - - - - 11 78.6 14 100.0 C15 Oesophagus 42 56.0 - - 7 9.3 - - - - 26 34.7 75 100.0 C16 Stomach 60 61.2 - - 5 5.1 - - - - 33 33.7 98 100.0 C17 Small Intestine 5 83.3 - - - - - - - - 1 16.7 6 100.0 C18 Colon 81 71.7 - - 3 2.7 - - - - 29 25.7 113 100.0 C19-C20 Rectum 52 77.6 - - 1 1.5 - - - - 14 20.9 67 100.0 C21 Anus & Anal Canal 9 69.2 - - 1 7.7 - - - - 3 23.1 13 100.0 C22 Liver 6 7.1 - - 29 34.5 - - - - 49 58.3 84 100.0 C23-C24 Gallbladder etc. 31 34.1 - - 14 15.4 - - - - 46 50.5 91 100.0 C25 Pancreas 17 27.9 - - 9 14.8 - - - - 35 57.4 61 100.0 C30-C31 Nose, Sinuses etc. 7 77.8 - - 1 11.1 - - - - 1 11.1 9 100.0 C32 Larynx 96 64.4 2 1.3 19 12.8 - - - - 32 21.5 149 100.0 C33-C34 Lung etc. 59 11.3 - - 302 57.6 - - - - 163 31.1 524 100.0 C37-C38 Other Thoracic Organs 1 11.1 - - 7 77.8 - - - - 1 11.1 9 100.0 C40-C41 Bone 18 54.5 - - 6 18.2 - - 1 3.0 8 24.2 33 100.0 C43 Melanoma of Skin 20 90.9 - - 2 9.1 - - - - - - 22 100.0 C44 Other Skin 15 83.3 - - - - - - - - 3 16.7 18 100.0 C45 Mesothelioma - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue 22 73.3 - - 7 23.3 - - - - 1 3.3 30 100.0 C50 Breast 12 50.0 - - 9 37.5 - - - - 3 12.5 24 100.0 C60 Penis 20 80.0 - - - - - - - - 5 20.0 25 100.0 C61 Prostate 161 70.3 1 0.4 10 4.4 - - 1 0.4 56 24.5 229 100.0 C62 Testis 19 95.0 - - - - - - - - 1 5.0 20 100.0 C63 Other Male Genital - - - - - - - - - - - - - - C64 Kidney etc. 32 56.1 1 1.8 9 15.8 - - - - 15 26.3 57 100.0 C65 Renal Pelvis - - - - - - - - - - - - - - C66 Ureter - - - - - - - - - - - - - - C67 Urinary Bladder 85 78.7 - - 1 0.9 - - 1 0.9 21 19.4 108 100.0 C68 Uns.Urinary Organs 1 50.0 - - - - - - - - 1 50.0 2 100.0 C69 Eye 5 100.0 - - - - - - - - - - 5 100.0 C70-C72 Brain, Nervous System 23 51.1 - - 6 13.3 - - - - 16 35.6 45 100.0 C73 Thyroid 14 48.3 - - 13 44.8 - - - - 2 6.9 29 100.0 C74 Adrenal Gland - - - - - - - - - - - - - - C81 Hodgkins Disease 7 23.3 - - 16 53.3 - - 1 3.3 6 20.0 30 100.0 C82-C85 NHL 32 38.6 2 2.4 29 34.9 - - - - 20 24.1 83 100.0 C88 Malig Imn.Prol D - - - - - - - - - - - - - - C90 Multiple Myeloma 3 6.5 - - - - - - 31 67.4 12 26.1 46 100.0 C91 Lymphoid Leuk. - - - - - - - - 19 82.6 4 17.4 23 100.0 C92-C94 Myeloid Leukaemia - - - - - - - - 37 67.3 18 32.7 55 100.0 C95 Leukaemia Uns - - - - - - - - 1 25.0 3 75.0 4 100.0 C96 CMD,O&U LMH - - - - - - - - - - - - - - O&U* Other and Uns 8 7.0 5 4.3 35 30.4 - - - - 67 58.3 115 100.0 All Sites 1322 47.6 13 0.5 581 20.9 - - 92 3.3 769 27.7 2777 100.0

TABLE KOL-6(b): Number (#) and Proportion (%) of Cancers by Site (ICD-10) and Detailed Microscopic Diagnosis: 2012 Females ICD-10 Site Pri. Hist Sec. Hist Cytology Blood Film Bone Marrow Others Total # % # % # % # % # % # % # % C00 Lip 4 66.7 - - - - - - - - 2 33.3 6 100.0 C01-C02 Tongue 46 76.7 - - 3 5.0 - - - - 11 18.3 60 100.0 C03-C06 Mouth 56 72.7 - - 7 9.1 - - - - 14 18.2 77 100.0 C07-C08 Salivary Gland 4 50.0 - - 4 50.0 - - - - - - 8 100.0 C09 Tonsil 6 66.7 - - 2 22.2 - - - - 1 11.1 9 100.0 C10 Oth. Oropharynx 4 100.0 - - - - - - - - - - 4 100.0 C11 Nasopharynx 2 66.7 - - - - - - - - 1 33.3 3 100.0 C12-C13 Hypopharynx 8 80.0 - - - - - - - - 2 20.0 10 100.0 C14 Pharynx Unspecified 1 25.0 - - - - - - - - 3 75.0 4 100.0 C15 Oesophagus 24 53.3 - - 1 2.2 - - - - 20 44.4 45 100.0 C16 Stomach 37 57.8 - - 6 9.4 - - - - 21 32.8 64 100.0 C17 Small Intestine 3 100.0 - - - - - - - - - - 3 100.0 C18 Colon 35 66.0 - - 1 1.9 - - - - 17 32.1 53 100.0 C19-C20 Rectum 31 63.3 - - 1 2.0 - - - - 17 34.7 49 100.0 C21 Anus & Anal Canal 8 100.0 - - - - - - - - - - 8 100.0 C22 Liver 5 12.2 1 2.4 14 34.1 - - - - 21 51.2 41 100.0 C23-C24 Gallbladder etc. 54 28.1 1 0.5 44 22.9 - - - - 93 48.4 192 100.0 C25 Pancreas 6 20.0 - - 9 30.0 - - - - 15 50.0 30 100.0 C30-C31 Nose, Sinuses etc. 4 100.0 - - - - - - - - - - 4 100.0 C32 Larynx 13 50.0 - - 6 23.1 - - - - 7 26.9 26 100.0 C33-C34 Lung etc. 16 8.6 1 0.5 103 55.7 - - - - 65 35.1 185 100.0 C37-C38 Other Thoracic Organs - - - - 9 90.0 - - - - 1 10.0 10 100.0 C40-C41 Bone 19 76.0 - - 4 16.0 - - - - 2 8.0 25 100.0 C43 Melanoma of Skin 14 77.8 - - 2 11.1 - - - - 2 11.1 18 100.0 C44 Other Skin 11 84.6 - - - - - - - - 2 15.4 13 100.0 C45 Mesothelioma - - - - - - - - - - - - - - C46 Kaposi Sarcoma - - - - - - - - - - - - - - C47+C49 Conn. & Soft Tissue 16 88.9 - - 1 5.6 - - - - 1 5.6 18 100.0 C50 Breast 418 63.3 - - 152 23.0 - - - - 90 13.6 660 100.0 C51 Vulva 10 90.9 - - - - - - - - 1 9.1 11 100.0 C52 Vagina 13 92.9 - - 1 7.1 - - - - - - 14 100.0 C53 Cervix Uteri 211 80.5 - - 5 1.9 - - - - 46 17.6 262 100.0 C54 Corpus Uteri 84 86.6 - - 1 1.0 - - - - 12 12.4 97 100.0 C55 Uterus Unspecified 12 38.7 - - - - - - - - 19 61.3 31 100.0 C56 Ovary etc. 127 62.6 3 1.5 25 12.3 - - - - 48 23.6 203 100.0 C57 Other Female Genital 1 100.0 - - - - - - - - - - 1 100.0 C58 Placenta - - - - - - - - - - - - - - C64 Kidney etc. 16 53.3 - - 6 20.0 - - - - 8 26.7 30 100.0 C65 Renal Pelvis - - - - - - - - - - - - - - C66 Ureter - - - - - - - - - - 1 100.0 1 100.0 C67 Urinary Bladder 14 82.4 - - 1 5.9 - - - - 2 11.8 17 100.0 C68 Uns.Urinary Organs 3 100.0 - - - - - - - - - - 3 100.0 C69 Eye 3 75.0 - - - - - - - - 1 25.0 4 100.0 C70-C72 Brain, Nervous System 20 64.5 - - 2 6.5 - - - - 9 29.0 31 100.0 C73 Thyroid 26 49.1 1 1.9 19 35.8 - - - - 7 13.2 53 100.0 C74 Adrenal Gland - - - - - - - - - - - - - - C81 Hodgkins Disease 4 30.8 - - 6 46.2 - - - - 3 23.1 13 100.0 C82-C85 NHL 20 39.2 - - 27 52.9 - - - - 4 7.8 51 100.0 C88 Malig Imn.Prol D - - - - - - - - - - - - - - C90 Multiple Myeloma 1 4.8 - - - - - - 13 61.9 7 33.3 21 100.0 C91 Lymphoid Leuk. - - - - - - - - 14 82.4 3 17.6 17 100.0 C92-C94 Myeloid Leukaemia 1 3.7 - - - - - - 19 70.4 7 25.9 27 100.0 C95 Leukaemia Uns - - - - - - - - 3 50.0 3 50.0 6 100.0 C96 CMD,O&U LMH - - - - - - - - - - - - - - O&U* Other and Uns 4 5.1 5 6.4 23 29.5 - - - - 46 59.0 78 100.0 All Sites 1415 54.5 12 0.5 485 18.7 - - 49 1.9 635 24.5 2596 100.0

TABLE KOL-7(a): Cumulative Rate (Cu.Rate%) & Cumulative Risk (Cu.Risk) of individual sites (ICD-10) based on age specific rates (from 0-64 and from 0-74 Years): 2012 Males ICD-10 Site 0-64 Years 0-74 Years Cu.Rate % Cu.Risk Cu.Rate % Cu.Risk C00 Lip 0.0 0.0 0.0 0.0 C01-C02 Tongue 0.4 0.4 0.6 0.6 C03-C06 Mouth 0.5 0.5 0.8 0.8 C07-C08 Salivary Gland 0.0 0.0 0.1 0.1 C09 Tonsil 0.0 0.0 0.1 0.1 C10 Oth. Oropharynx 0.0 0.0 0.0 0.0 C11 Nasopharynx 0.0 0.0 0.0 0.0 C12-C13 Hypopharynx 0.1 0.1 0.3 0.3 C14 Pharynx Unspecified 0.0 0.0 0.1 0.1 C15 Oesophagus 0.1 0.1 0.3 0.3 C16 Stomach 0.2 0.2 0.5 0.5 C17 Small Intestine 0.0 0.0 0.0 0.0 C18 Colon 0.3 0.3 0.4 0.4 C19-C20 Rectum 0.2 0.2 0.3 0.3 C21 Anus & Anal Canal 0.0 0.0 0.0 0.0 C22 Liver 0.2 0.2 0.4 0.4 C23-C24 Gallbladder etc. 0.2 0.2 0.4 0.4 C25 Pancreas 0.1 0.1 0.3 0.3 C30-C31 Nose, Sinuses etc. 0.0 0.0 0.0 0.0 C32 Larynx 0.3 0.3 0.7 0.7 C33-C34 Lung etc. 1.0 1.0 2.5 2.4 C37-C38 Other Thoracic Organs 0.0 0.0 0.0 0.0 C40-C41 Bone 0.1 0.1 0.1 0.1 C43 Melanoma of Skin 0.1 0.1 0.1 0.1 C44 Other Skin 0.0 0.0 0.1 0.1 C45 Mesothelioma - - - - C46 Kaposi Sarcoma - - - - C47+C49 Conn. & Soft Tissue 0.1 0.1 0.1 0.1 C50 Breast 0.1 0.1 0.1 0.1 C60 Penis 0.1 0.1 0.1 0.1 C61 Prostate 0.2 0.2 0.9 0.9 C62 Testis 0.1 0.1 0.1 0.1 C63 Other Male Genital - - - - C64 Kidney etc. 0.1 0.1 0.2 0.2 C65 Renal Pelvis - - - - C66 Ureter - - - - C67 Urinary Bladder 0.2 0.2 0.5 0.5 C68 Uns.Urinary Organs 0.0 0.0 0.0 0.0 C69 Eye 0.0 0.0 0.0 0.0 C70-C72 Brain, Nervous System 0.1 0.1 0.2 0.2 C73 Thyroid 0.1 0.1 0.1 0.1 C74 Adrenal Gland - - - - C81 Hodgkins Disease 0.1 0.1 0.1 0.1 C82-C85 NHL 0.2 0.2 0.3 0.3 C88 Malig Imn.Prol D - - - - C90 Multiple Myeloma 0.1 0.1 0.2 0.2 C91 Lymphoid Leuk. 0.1 0.1 0.1 0.1 C92-C94 Myeloid Leukaemia 0.1 0.1 0.2 0.2 C95 Leukaemia Uns 0.0 0.0 0.0 0.0 C96 CMD,O&U LMH - - - - O&U* Other and Uns 0.2 0.2 0.5 0.5 All Sites 5.87 5.70 11.92 11.24

TABLE KOL-7(b): Cumulative Rate (Cu.Rate%) & Cumulative Risk (Cu.Risk) of individual sites (ICD-10) based on age specific rates (from 0-74 and from 0-74 Years): 2012 Females ICD-10 Site 0-64 Years 0-74 Years Cu.Rate % Cu.Risk Cu.Rate % Cu.Risk C00 Lip 0.0 0.0 0.0 0.0 C01-C02 Tongue 0.2 0.2 0.3 0.3 C03-C06 Mouth 0.2 0.2 0.3 0.3 C07-C08 Salivary Gland 0.0 0.0 0.0 0.0 C09 Tonsil 0.0 0.0 0.0 0.0 C10 Oth. Oropharynx 0.0 0.0 0.0 0.0 C11 Nasopharynx 0.0 0.0 0.0 0.0 C12-C13 Hypopharynx 0.0 0.0 0.1 0.1 C14 Pharynx Unspecified - - 0.0 0.0 C15 Oesophagus 0.1 0.1 0.2 0.2 C16 Stomach 0.2 0.2 0.3 0.3 C17 Small Intestine 0.0 0.0 0.0 0.0 C18 Colon 0.1 0.1 0.3 0.3 C19-C20 Rectum 0.1 0.1 0.2 0.2 C21 Anus & Anal Canal 0.0 0.0 0.0 0.0 C22 Liver 0.1 0.1 0.2 0.2 C23-C24 Gallbladder etc. 0.5 0.5 0.9 0.9 C25 Pancreas 0.1 0.1 0.1 0.1 C30-C31 Nose, Sinuses etc. 0.0 0.0 0.0 0.0 C32 Larynx 0.1 0.1 0.1 0.1 C33-C34 Lung etc. 0.4 0.4 0.9 0.9 C37-C38 Other Thoracic Organs 0.0 0.0 0.0 0.0 C40-C41 Bone 0.1 0.1 0.1 0.1 C43 Melanoma of Skin 0.0 0.0 0.1 0.1 C44 Other Skin 0.0 0.0 0.1 0.1 C45 Mesothelioma - - - - C46 Kaposi Sarcoma - - - - C47+C49 Conn. & Soft Tissue 0.0 0.0 0.1 0.1 C50 Breast 2.0 1.9 2.8 2.8 C51 Vulva 0.0 0.0 0.1 0.1 C52 Vagina 0.0 0.0 0.1 0.1 C53 Cervix Uteri 0.8 0.8 1.2 1.2 C54 Corpus Uteri 0.3 0.3 0.5 0.5 C55 Uterus Unspecified 0.1 0.1 0.1 0.1 C56 Ovary etc. 0.6 0.6 0.9 0.9 C57 Other Female Genital - - - - C58 Placenta - - - - C64 Kidney etc. 0.1 0.1 0.1 0.1 C65 Renal Pelvis - - - - C66 Ureter - - 0.0 0.0 C67 Urinary Bladder 0.0 0.0 0.1 0.1 C68 Uns.Urinary Organs 0.0 0.0 0.0 0.0 C69 Eye 0.0 0.0 0.0 0.0 C70-C72 Brain, Nervous System 0.1 0.1 0.1 0.1 C73 Thyroid 0.2 0.2 0.2 0.2 C74 Adrenal Gland - - - - C81 Hodgkins Disease 0.0 0.0 0.0 0.0 C82-C85 NHL 0.1 0.1 0.2 0.2 C88 Malig Imn.Prol D - - - - C90 Multiple Myeloma 0.1 0.1 0.1 0.1 C91 Lymphoid Leuk. 0.0 0.0 0.1 0.1 C92-C94 Myeloid Leukaemia 0.1 0.1 0.1 0.1 C95 Leukaemia Uns 0.0 0.0 0.0 0.0 C96 CMD,O&U LMH - - - - O&U* Other and Uns 0.2 0.2 0.4 0.4 All Sites 7.18 6.93 11.72 11.06

2024 © travelsdocbox.com Privacy Policy | Terms of Service | Feedback